GoodRx Holdings (GDRX) Income from Continuing Operations (2019 - 2026)

GoodRx Holdings has disclosed Income from Continuing Operations across 8 years of filings, most recently posting 1169000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 1169000.0, down 89.42% year-over-year; the trailing twelve-month figure through Mar 2026 was 20556000.0 (down 27.75% YoY), and the FY2025 annual result was 30439000.0, up 85.72% from the prior year.
• Income from Continuing Operations came in at 1169000.0 for Q1 2026 at GoodRx Holdings, down from 5425000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 58786000.0 in Q2 2023 to a low of 41734000.0 in Q3 2022.
• The 5-year median for Income from Continuing Operations is 1169000.0 (2026), against an average of 370705.88.
• Peak annual rise in Income from Continuing Operations reached 4254.49% in 2023, while the deepest fall reached 1211.82% in 2023.
• GoodRx Holdings' Income from Continuing Operations stood at 1972000.0 in 2022, then slumped by 1211.82% to 25869000.0 in 2023, then soared by 126.05% to 6740000.0 in 2024, then declined by 19.51% to 5425000.0 in 2025, then tumbled by 78.45% to 1169000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 1169000.0 (Q1 2026), 5425000.0 (Q4 2025), and 1119000.0 (Q3 2025), per Business Quant data.